VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Siegel, David S., Dimopoulos, Meletios, Jagannath, Sundar, Goldschmidt, Hartmut, Durrant, Simon, Kaufman, Jonathan L., Leleu, Xavier, Nagler, Arnon, Offner, Fritz, Graef, Thorsten, Eid, Joseph E., HouLanguage:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2016.02.042
Date:
March, 2016
File:
PDF, 1.27 MB
english, 2016